Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
Authors
Keywords
-
Journal
HEADACHE
Volume 59, Issue 10, Pages 1743-1752
Publisher
Wiley
Online
2019-11-01
DOI
10.1111/head.13654
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Humanistic and economic burden of nausea and vomiting among migraine sufferers
- (2017) Kavita Gajria et al. Journal of Pain Research
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Systematic Review of Migraine Prophylaxis Adherence and Persistence
- (2016) Zsolt Hepp et al. JOURNAL OF MANAGED CARE PHARMACY
- TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine
- (2015) Sarah Walter et al. Current Pain and Headache Reports
- Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
- (2015) Richard B. Lipton et al. HEADACHE
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
- (2013) Marcelo E Bigal et al. CEPHALALGIA
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
- (2013) Andrew M. Blumenfeld et al. HEADACHE
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
- (2013) Marcelo E. Bigal et al. HEADACHE
- Prophylaxis of migraine: general principles and patient acceptance
- (2011) Domenico D'Amico et al. Neuropsychiatric Disease and Treatment
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
- (2008) S Silberstein et al. CEPHALALGIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started